Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Gene Therapy00:59

Gene Therapy

25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Experimental RNAi02:15

Experimental RNAi

6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference01:23

RNA Interference

26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

15.2K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
15.2K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A transcriptomic map of ligand-receptor interactions within bovine antral follicles predicts intrafollicular factors for improving oocyte quality.

Journal of animal science and biotechnology·2026
Same author

Clinical Features and Gene Mutation of Neonatal Seizures.

Journal of clinical medicine·2026
Same author

Single-nucleus transcriptomics-based drug screening platform for focal cortical dysplasia.

Molecular psychiatry·2026
Same author

Copper-Catalyzed Difluoromethylborylation of Unactivated Alkenes Enabled by an NMP Stabilized ICF<sub>2</sub>H Reagent.

Organic letters·2026
Same author

TREM2 mediates macrophage suppression of NLRP3 inflammasome pathway to promote non-small cell lung cancer progression.

Molecular and cellular biochemistry·2026
Same author

In Vivo Confocal Microscopy Revealed Alteration of Limbal Stem Cells and Sub-Basal Nerve Plexus in Allergic and Dry Eye-Related Ocular Surface Diseases.

Translational vision science & technology·2026

相关实验视频

Updated: Jun 22, 2025

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents
09:18

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

5.6K

在基因治疗中抑制器tRNA.

Jingjing Ruan1,2, Xiaoxiao Yu2, Huixia Xu3

  • 1The Children's Hospital, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Liangzhu Laboratory, Hangzhou, 310000, China.

Science China. Life sciences
|June 26, 2024
PubMed
概括

抑制转移RNAs (tRNAs) 通过使全长蛋白质的产生成为可能,为无意义突变疾病提供了一个有前途的基因疗法方法. 本综述探讨了它们的机制,应用和治疗潜力.

关键词:
在PTC中使用PTC.基因治疗的基因疗法没有意义的突变突变.阅读通过通过.这是一种抑制剂tRNA抑制剂.

更多相关视频

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.4K
Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.4K

相关实验视频

Last Updated: Jun 22, 2025

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents
09:18

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

5.6K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.4K
Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.4K

科学领域:

  • 分子生物学分子生物学
  • 遗传学 是一个遗传学.
  • 生物技术是生物技术.

背景情况:

  • 无意义的突变导致过早终止的子 (PTC),导致截断的,非功能性蛋白质.
  • 这些突变导致各种遗传疾病,突显了需要有效的治疗策略.
  • 抑制转移RNAs (tRNAs) 是细胞蛋白质合成中的关键分子.

研究的目的:

  • 审查基因治疗中抑制器tRNAs的机制和发展.
  • 将抑制器tRNA与替代阅读疗法进行比较.
  • 讨论抑制器tRNAs的临床潜力,局限性和应用.

主要方法:

  • 审查关于抑制器tRNA技术的现有文献.
  • 对不同的阅读治疗方法进行比较分析.
  • 抑制器tRNAs在体外和体内应用的总结.

主要成果:

  • 抑制器tRNA可以识别PTC,使核糖体读透和合成全长蛋白质.
  • 这项技术在治疗由无意义突变引起的遗传疾病方面具有重大前景.
  • 在实验室和临床环境中探索了各种应用.

结论:

  • 抑制器tRNAs代表了无意义突变疾病的可行的治疗策略.
  • 需要进一步的研究来克服局限性并优化临床应用.
  • 这种方法为治疗来自PTCs的遗传疾病提供了新的见解.